Rafferty Asset Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
Rafferty Asset Management's KURA Position: Q3 2026 in Review
Rafferty Asset Management increased its Kura Oncology (KURA) stake by 29% in Q3 2026, buying an estimated $278K and bringing the position to 110,319 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #736.
Rafferty Asset Management first reported a position in KURA in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.64M in Q1 2024. 230 funds tracked by Wall St. Rank hold KURA as of Q3 2026.
- Rafferty Asset Management held 110,319 shares of Kura Oncology worth $1.18M as of Q3 2026.
- Rafferty Asset Management bought 24,833 Kura Oncology shares in Q3 2026, an estimated $278K.
- Kura Oncology made up ﹤0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #736 holding.
- Rafferty Asset Management first reported a position in Kura Oncology in Q1 2019 and has held it in 30 quarters since.
- Rafferty Asset Management's Kura Oncology position peaked at $6.64M in Q1 2024.
- 230 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.